Document is current
Any future updates will be listed below
-
Authors
Le-Trilling, Vu Thuy Khanh http://orcid.org/0000-0002-2733-3732
Mennerich, Denise
Schuler, Corinna
Sakson, Roman
Lill, Julia K.
Kasarla, Siva Swapna
Kopczynski, Dominik
Loroch, Stefan
Flores-Martinez, Yulia
Katschinski, Benjamin
Wohlgemuth, Kerstin
Gunzer, Matthias
Meyer, Folker
Phapale, Prasad
Dittmer, Ulf
Sickmann, Albert
Trilling, Mirko http://orcid.org/0000-0003-3659-3541
-
Funding
Funding for this research was provided by:
Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen (313-8.04.10.02-149281)
Deutsche Forschungsgemeinschaft (TRR 240 Z02, SFB 1116 S01)
Bundesministerium für Bildung und Forschung (161L0271, 161L0271)
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Received: 20 April 2022
Accepted: 17 November 2022
First Online: 30 November 2022
Declarations
:
: The isolation of SARS-CoV-2 has been approved by the ethics committee of the medical faculty of the University of Duisburg-Essen (20–9511-BO and 20–9512-BO).
: Not applicable.
: VTKLT, DM, CS, YFM, BK, KW, UD, and MT are the inventors of a pending patent application dealing with the anti-coronavirus activity of caffeic acid, perilla aldehyde, and perillyl alcohol submitted by the University of Duisburg-Essen. The other authors declare no competing interests.
